Current Studies – CLA Research

Looking for a new way to manage your depression? (RENEW-MDD-2)

Learn about a second clinical trial studying a new investigational medication that may help adults with major depressive disorder (MDD) stay well for longer — used together with their current treatment.

Could more seizure-free days be in your future?

Learn about a clinical trial evaluating vormatrigine, a new investigational medication that may help reduce focal onset seizures in adults.

Living with schizophrenia? This study may be for you.

Learn about a clinical trial studying a new investigational medication that may help adults with schizophrenia manage their weight, improve their thinking and memory, and remain stable for longer — used together with their current treatment.

Looking for a new way to manage your depression?

Learn about a clinical trial studying a new investigational medication that may help adults with major depressive disorder (MDD) stay well for longer — used together with their current treatment.

Looking for a new way to manage your bipolar disorder?

Learn about a clinical trial studying a new investigational medication that may help adults with bipolar disorder 1 or 2 stay well for longer — used together with their current treatment.

Could there be more seizure-free days in your future?

Learn about a clinical trial evaluating a new investigational medication that may help reduce seizures in adults.

The requirements to participate are the following:

Be 18 to 75 years old.
At least two focal-onset seizures per month for patients with focal-onset epilepsy, or 1 generalized tonic-clonic seizure per month.
You are taking 1 to 3 anticonvulsant medications

Phase 2 clinical trial in adults with focal or generalized seizures

Open Label Clinical Trial to Evaluate the Efficacy and Safety of XXXX in Adult Patients with Focal Onset or Primary Generalized Tonic -Clonic Seizures.